ArticleFrontiers in neurology2025
Synergistic effects of hyperbaric oxygen therapy combined with MPNFS nursing model on neurological recovery and recurrence prevention after chronic subdural hematoma surgery.
Article in Frontiers in neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Chronic subdural hematoma (CSDH) has high postoperative recurrence rates. This study investigates the effects of hyperbaric oxygen therapy (HBOT) combined with Medical-Psychosocial-Nursing Functional Support (MPNFS) on functional recovery and recurrence prevention in CSDH patients, and establishes a recurrence prediction model. Methods: A total of 184 CSDH patients undergoing burr hole drainage were randomized into a control group and an observation group (HBOT + MPNFS). Neurological (NIHSS), motor (Fugl-Meyer Assessment), and quality-of-life (SF-36) outcomes were assessed preoperatively and at 1-month postoperatively. Complications and 6-month recurrence rates were recorded. Univariate/multivariate logistic regression identified recurrence risk factors, with ROC analysis evaluating predictive accuracy. Results: The observation group showed superior 1-month outcomes: lower NIHSS scores ( Conclusion: Hyperbaric oxygen therapy combined with MPNFS enhances neurological/motor recovery, improves quality of life, and reduces complications/recurrence in postoperative CSDH patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.